Inactivating Mutations of the Human Luteinizing Hormone Receptor in Both Sexes
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | LATRONICO, Ana Claudia | |
dc.contributor.author | ARNHOLD, Ivo J. P. | |
dc.date.accessioned | 2013-07-30T14:41:59Z | |
dc.date.available | 2013-07-30T14:41:59Z | |
dc.date.issued | 2012 | |
dc.description.abstract | The human luteinizing hormone/chorionic gonadotropin receptor (LHCGR) plays a fundamental role in male and female reproductive physiology. Over the past 15 years, several homozygous or compound heterozygous loss-of-function mutations in the LHCGR gene have been described in males and females. In genetic males, mutations in LHCGR were associated with distinct degrees of impairment in pre- and postnatal testosterone secretion resulting in a phenotypic spectrum. Patients with the severe form of LH resistance have predominantly female external genitalia and absence of secondary sex differentiation at puberty. Patients with milder forms have predominantly male external genitalia with micropenis and/or hypospadias or only infertility without ambiguity. The undermasculization is associated with low basal, as well as human CG-stimulated, testosterone levels and elevated LH levels after pubertal age, without abnormal step-up in testosterone biosynthesis precursors. The testes have only slightly reduced size but mature Leydig cells are absent or scarce (Leydig cell hypoplasia). Genetic females with inactivating LHCGR mutations have female external genitalia, spontaneous breast and pubic hair development at puberty, and normal or late menarche followed by oligoamenorrhea and infertility. Estradiol and progesterone levels are normal for the early to midfollicular phase, but do not reach ovulatory or luteal phase levels. Serum LH levels are high whereas follicle-stimulating hormone levels are normal or only slightly increased. Pelvic ultrasound has demonstrated a small or normal uterus and normal or enlarged ovaries with cysts. The inactivating mutations of the LHCGR have provided important insights into distinct physiological roles of LH in reproduction of both sexes. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/04726-0] | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [300982/2009-7, 300469/2005] | |
dc.identifier.citation | SEMINARS IN REPRODUCTIVE MEDICINE, v.30, n.5, p.382-386, 2012 | |
dc.identifier.doi | 10.1055/s-0032-1324721 | |
dc.identifier.issn | 1526-8004 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/512 | |
dc.language.iso | eng | |
dc.publisher | THIEME MEDICAL PUBL INC | |
dc.relation.ispartof | Seminars in Reproductive Medicine | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright THIEME MEDICAL PUBL INC | |
dc.subject | LH receptor | |
dc.subject | amenorrhea | |
dc.subject | infertility | |
dc.subject.other | empty-follicle-syndrome | |
dc.subject.other | leydig-cell hypoplasia | |
dc.subject.other | human chorionic-gonadotropin | |
dc.subject.other | male pseudohermaphroditism | |
dc.subject.other | missense mutation | |
dc.subject.other | ovarian resistance | |
dc.subject.other | male hypogonadism | |
dc.subject.other | gene | |
dc.subject.other | lh | |
dc.subject.other | phenotype | |
dc.subject.wos | Obstetrics & Gynecology | |
dc.subject.wos | Reproductive Biology | |
dc.title | Inactivating Mutations of the Human Luteinizing Hormone Receptor in Both Sexes | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.citation.scopus | 43 | |
hcfmusp.contributor.author-fmusphc | ANA CLAUDIA LATRONICO XAVIER | |
hcfmusp.contributor.author-fmusphc | IVO JORGE PRADO ARNHOLD | |
hcfmusp.description.beginpage | 382 | |
hcfmusp.description.endpage | 386 | |
hcfmusp.description.issue | 5 | |
hcfmusp.description.volume | 30 | |
hcfmusp.lim.ref | 2012 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 23044874 | |
hcfmusp.origem.scopus | 2-s2.0-84866973513 | |
hcfmusp.origem.wos | WOS:000309018300007 | |
hcfmusp.publisher.city | NEW YORK | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Arnhold IJP, 1999, CLIN ENDOCRINOL, V51, P701, DOI 10.1046/j.1365-2265.1999.00863.x | |
hcfmusp.relation.reference | Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141 | |
hcfmusp.relation.reference | BERTHEZENE F, 1976, NEW ENGL J MED, V295, P969, DOI 10.1056/NEJM197610282951801 | |
hcfmusp.relation.reference | Bruysters M, 2008, HUM REPROD, V23, P1917, DOI 10.1093/humrep/den180 | |
hcfmusp.relation.reference | Gromoll J, 2000, J CLIN ENDOCR METAB, V85, P2281, DOI 10.1210/jc.85.6.2281 | |
hcfmusp.relation.reference | Huhtaniemi I, 2006, BEST PRACT RES CL EN, V20, P561, DOI 10.1016/j.beem.2006.09.003 | |
hcfmusp.relation.reference | Kossack N, 2008, PLOS MED, V5, P669, DOI 10.1371/journal.pmed.0050088 | |
hcfmusp.relation.reference | KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160 | |
hcfmusp.relation.reference | Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805 | |
hcfmusp.relation.reference | Latronico AC, 1999, AM J HUM GENET, V65, P949, DOI 10.1086/302602 | |
hcfmusp.relation.reference | Latronico AC, 1998, MOL ENDOCRINOL, V12, P442, DOI 10.1210/me.12.3.442 | |
hcfmusp.relation.reference | LAUE L, 1995, HUM MOL GENET, V4, P1429, DOI 10.1093/hmg/4.8.1429 | |
hcfmusp.relation.reference | Laue LL, 1996, MOL ENDOCRINOL, V10, P987, DOI 10.1210/me.10.8.987 | |
hcfmusp.relation.reference | Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184 | |
hcfmusp.relation.reference | Martens JWM, 1998, MOL ENDOCRINOL, V12, P775, DOI 10.1210/me.12.6.775 | |
hcfmusp.relation.reference | Misrahi M, 1997, J CLIN ENDOCR METAB, V82, P2159, DOI 10.1210/jc.82.7.2159 | |
hcfmusp.relation.reference | Muller T, 2003, J CLIN ENDOCR METAB, V88, P2242, DOI 10.1210/jc.2002-021946 | |
hcfmusp.relation.reference | Onalan G, 2003, HUM REPROD, V18, P1864, DOI 10.1093/humrep/deg371 | |
hcfmusp.relation.reference | Qiao J, 2009, HUM MUTAT, V30, pE855, DOI 10.1002/humu.21072 | |
hcfmusp.relation.reference | Richard N, 2011, ENDOCR J, V58, P769 | |
hcfmusp.relation.reference | Segaloff DL, 2009, PROG MOL BIOL TRANSL, V89, P97, DOI 10.1016/S1877-1173(09)89004-2 | |
hcfmusp.relation.reference | Stavrou SS, 1998, J CLIN ENDOCR METAB, V83, P2091, DOI 10.1210/jc.83.6.2091 | |
hcfmusp.relation.reference | Themmen APN, 2005, REPRODUCTION, V130, P263, DOI 10.1530/rep.1.00663 | |
hcfmusp.relation.reference | Toledo SPA, 1996, J CLIN ENDOCR METAB, V81, P3850, DOI 10.1210/jc.81.11.3850 | |
hcfmusp.relation.reference | Vujisic S, 2005, HUM REPROD, V20, P2552, DOI 10.1093/humrep/dei083 | |
hcfmusp.relation.reference | Yariz KO, 2011, FERTIL STERIL, V96, pE125, DOI 10.1016/j.fertnstert.2011.05.057 | |
hcfmusp.relation.reference | Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172 | |
hcfmusp.relation.reference | Zreik TG, 2000, HUM REPROD, V15, P999, DOI 10.1093/humrep/15.5.999 | |
hcfmusp.remissive.sponsorship | CNPq | |
hcfmusp.remissive.sponsorship | FAPESP | |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | 8ceff58e-e048-497c-9b17-0fe099ac7631 | |
relation.isAuthorOfPublication | a8b0af8f-cf8d-4dcf-b2a6-63604abc6b5c | |
relation.isAuthorOfPublication.latestForDiscovery | 8ceff58e-e048-497c-9b17-0fe099ac7631 |